LENZ Therapeutics, Inc. (LENZ)
4.52
-0.20
(-4.24%)
USD |
NASDAQ |
Sep 11, 16:00
4.52
0.00 (0.00%)
After-Hours: 06:24
LENZ Therapeutics Price : 4.52 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 4.71 | 4.77 | 4.50 | 4.52 | 978253.0 |
| Sep 10, 2026 | 4.85 | 4.88 | 4.68 | 4.72 | 569055.0 |
| Sep 09, 2026 | 5.31 | 5.405 | 4.885 | 4.91 | 705802.0 |
| Sep 08, 2026 | 5.95 | 5.95 | 5.32 | 5.33 | 642872.0 |
| Sep 04, 2026 | 5.75 | 5.98 | 5.615 | 5.96 | 488957.0 |
| Sep 03, 2026 | 5.90 | 5.97 | 5.65 | 5.83 | 835136.0 |
| Sep 02, 2026 | 5.21 | 5.81 | 5.21 | 5.80 | 993294.0 |
| Sep 01, 2026 | 5.17 | 5.305 | 5.00 | 5.23 | 605582.0 |
| Aug 31, 2026 | 5.06 | 5.275 | 5.008 | 5.21 | 713740.0 |
| Aug 28, 2026 | 4.80 | 5.13 | 4.69 | 5.11 | 680206.0 |
| Aug 27, 2026 | 4.78 | 4.833 | 4.718 | 4.81 | 439222.0 |
| Aug 26, 2026 | 4.67 | 4.84 | 4.58 | 4.78 | 546041.0 |
| Aug 25, 2026 | 4.58 | 4.81 | 4.58 | 4.67 | 542227.0 |
| Aug 24, 2026 | 4.65 | 4.70 | 4.547 | 4.59 | 497911.0 |
| Aug 21, 2026 | 4.71 | 4.81 | 4.67 | 4.68 | 475322.0 |
| Aug 20, 2026 | 4.88 | 4.90 | 4.575 | 4.66 | 567525.0 |
| Aug 19, 2026 | 4.82 | 5.036 | 4.81 | 4.92 | 583508.0 |
| Aug 18, 2026 | 4.77 | 4.89 | 4.74 | 4.77 | 534407.0 |
| Aug 17, 2026 | 4.71 | 4.82 | 4.60 | 4.79 | 804836.0 |
| Aug 14, 2026 | 4.63 | 4.87 | 4.63 | 4.73 | 702706.0 |
| Aug 13, 2026 | 5.02 | 5.25 | 4.535 | 4.60 | 1.428M |
| Aug 12, 2026 | 5.93 | 6.74 | 5.01 | 5.04 | 2.139M |
| Aug 11, 2026 | 5.41 | 5.48 | 5.05 | 5.21 | 530037.0 |
| Aug 10, 2026 | 5.38 | 5.478 | 5.29 | 5.36 | 441846.0 |
| Aug 07, 2026 | 5.29 | 5.42 | 5.21 | 5.36 | 452968.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Impact BioMedical, Inc. | 0.4602 |
| Enveric Biosciences, Inc. | 1.42 |
| Ocular Therapeutix, Inc. | 10.49 |
| Liquidia Corp. | 66.74 |
| Aquestive Therapeutics, Inc. | 4.78 |
Price Related Metrics
| PS Ratio | 6.437 |
| PEG Ratio | -0.0096 |
| Price to Book Value | 0.6476 |
| Earnings Yield | -90.29% |
| Market Cap | 142.00M |
| PEGY Ratio | -0.0096 |